Question Everything. See who's reporting it.

Aurobindo Launches Generic Advair Diskus in U.S.

Source: The Hindu

The story in brief

Aurobindo Pharma's subsidiary Lannett launched a generic Advair Diskus, approved by the FTC after its acquisition. The drug, treating asthma and COPD, is the first from Aurobindo's inhalation pipeline to be commercialized in the U.S., reflecting its focus on complex inhalation products. The generic is available in 100/50 mcg and 250/50 mcg strengths. Aurobindo received U.S. approval in June, following the FTC's approval of its acquisition of Lannett.

NEWXFree on Android and iPhone. Open in NEWX